Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Casadebaig

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 7, 2003
Synthesis and thrombolytic activity of new thienopyrimidinone derivativesJ P Dupin, R J Gryglewski, D Gravier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Schizophrenic patients: physical health and access to somatic careF Casadebaig, A Philippe, J M Guillaud-Bataille, et al.
Thrombosis Research|December 15, 1991
Action of some salicylate derivatives on in vitro platelet aggregation. Inhibitory and inhibition antagonistic effectsF Casadebaig, J P Dupin, D Gravier, et al.
International Journal of Technology Assessment in Health Care|May 18, 2000
Assessing the impact of a consensus conference on long-term therapy for schizophreniaJ Glikman, L Pazart, F Casadebaig, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 24, 2001
Thrombolysis by thienopyridines and their congenersR J Gryglewski, J P Dupin, W Uracz, et al.
L'Encephale|February 11, 2000
[The study of the impact of the consensus conference "Strategies for long-term therapy of patients with schizophrenia"]J Glikman, L Pazart, F Casadebaig, et al.
L'Encephale|April 25, 2002
[Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia]A Brunot, B Lachaux, H Sontag, et al.
L'Encephale|June 17, 2005
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]P M Llorca, H Miadi-Fargier, C Lançon, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 7, 2003
Synthesis and thrombolytic activity of new thienopyrimidinone derivativesJ P Dupin, R J Gryglewski, D Gravier, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Schizophrenic patients: physical health and access to somatic careF Casadebaig, A Philippe, J M Guillaud-Bataille, et al.
Thrombosis Research|December 15, 1991
Action of some salicylate derivatives on in vitro platelet aggregation. Inhibitory and inhibition antagonistic effectsF Casadebaig, J P Dupin, D Gravier, et al.
International Journal of Technology Assessment in Health Care|May 18, 2000
Assessing the impact of a consensus conference on long-term therapy for schizophreniaJ Glikman, L Pazart, F Casadebaig, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 24, 2001
Thrombolysis by thienopyridines and their congenersR J Gryglewski, J P Dupin, W Uracz, et al.
L'Encephale|February 11, 2000
[The study of the impact of the consensus conference "Strategies for long-term therapy of patients with schizophrenia"]J Glikman, L Pazart, F Casadebaig, et al.
L'Encephale|April 25, 2002
[Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia]A Brunot, B Lachaux, H Sontag, et al.
L'Encephale|June 17, 2005
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]P M Llorca, H Miadi-Fargier, C Lançon, et al.
Pageof 3